The use of digoxin for atrial fibrillation (AF) treatment has decreased over time in the US, but "without a concomitant increase in the use of other agents for rate control"

By  

Inpharma, Vol. 1, Iss. 1425, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Warfarin prescribing in atrial fibrillation (AF) was significantly improved with an educational programme

By  

Inpharma, Vol. 1, Iss. 1470, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Postoperative NSAID use is associated with a decrease in the odds of developing atrial fibrillation (AF) after cardiothoracic surgery

By  

Inpharma, Vol. 1, Iss. 1635, 2008-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Omega-3 fatty acid supplementation appears to reduce 1-year atrial fibrillation (AF) risk

By  

Inpharma, Vol. 1, Iss. 1648, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Azimilide reduced the incidence of atrial fibrillation (AF) but had no effect on mortality in patients with left ventricular dysfunction after recent myocardial infarction

By  

Inpharma, Vol. 1, Iss. 1435, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite